{"transactions":[{"id":3827477,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":163840,"kind":"organization","name":"THIRD ROCK VENTURES LP","position":1,"cik":"0001408591","reported_name":"THIRD ROCK VENTURES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163841,"kind":"organization","name":"Third Rock Ventures GP, L.P.","position":2,"cik":"0001578976","reported_name":"Third Rock Ventures GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105938,"kind":"organization","name":"TRV GP, LLC","position":3,"cik":"0001578973","reported_name":"TRV GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-09-04T16:06:06.000Z","date":"2018-08-30","kind":"other","acquired":false,"shares":1000000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a Rule 10b5-1 trading plan adopted by Third Rock Ventures, L.P. (\"TRV\"), Third Rock Ventures GP, L.P. (\"TRV GP\") and TRV GP, LLC (\"TRV GP LLC\"), TRV distributed on August 30, 2018, for no consideration, 1,000,000 shares of Common Stock of the Issuer (the \"Shares\") to its limited partners and to TRV GP, the general partner of TRV, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP distributed, for no consideration, the Shares it received in the distribution by TRV to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a Rule 10b5-1 trading plan adopted by Third Rock Ventures, L.P. (\"TRV\"), Third Rock Ventures GP, L.P. (\"TRV GP\") and TRV GP, LLC (\"TRV GP LLC\"), TRV distributed on August 30, 2018, for no consideration, 1,000,000 shares of Common Stock of the Issuer (the \"Shares\") to its limited partners and to TRV GP, the general partner of TRV, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP distributed, for no consideration, the Shares it received in the distribution by TRV to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by TRV. The general partner of TRV is TRV GP. The general partner of TRV GP is TRV GP LLC. The individual managers of TRV GP LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP, TRV GP LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":2981437,"source":{"system":"sec-edgar","filing":"0000899243-18-023708","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924318023708/doc4.xml","form_type":"4"}},{"id":3834104,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":163840,"kind":"organization","name":"THIRD ROCK VENTURES LP","position":1,"cik":"0001408591","reported_name":"THIRD ROCK VENTURES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163841,"kind":"organization","name":"Third Rock Ventures GP, L.P.","position":2,"cik":"0001578976","reported_name":"Third Rock Ventures GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105938,"kind":"organization","name":"TRV GP, LLC","position":3,"cik":"0001578973","reported_name":"TRV GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2018-08-24T16:05:23.000Z","date":"2018-08-22","kind":"other","acquired":false,"shares":51032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The warrant was fully exercisable upon grant."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are directly held by Third Rock Ventures, L.P. (\"TRV\"). The general partner of TRV is Third Rock Ventures GP, L.P. (\"TRV GP\"). The general partner of TRV GP is TRV GP, LLC (\"TRV GP LLC\"). The individual managers of TRV GP LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP, TRV GP LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares"}],"balance_after":0,"derivative":{"exercise_price":1.55,"expiration_date":"2021-05-24","underlying":"Common Stock","underlying_shares":51032},"source":{"system":"sec-edgar","filing":"0000899243-18-023212","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924318023212/doc4.xml","form_type":"4"}},{"id":3834103,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":163840,"kind":"organization","name":"THIRD ROCK VENTURES LP","position":1,"cik":"0001408591","reported_name":"THIRD ROCK VENTURES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163841,"kind":"organization","name":"Third Rock Ventures GP, L.P.","position":2,"cik":"0001578976","reported_name":"Third Rock Ventures GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105938,"kind":"organization","name":"TRV GP, LLC","position":3,"cik":"0001578973","reported_name":"TRV GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-24T16:05:23.000Z","date":"2018-08-22","kind":"other","acquired":true,"shares":51032,"price":1.55,"value":79099.6,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are directly held by Third Rock Ventures, L.P. (\"TRV\"). The general partner of TRV is Third Rock Ventures GP, L.P. (\"TRV GP\"). The general partner of TRV GP is TRV GP, LLC (\"TRV GP LLC\"). The individual managers of TRV GP LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP, TRV GP LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares"}],"balance_after":3034083,"source":{"system":"sec-edgar","filing":"0000899243-18-023212","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924318023212/doc4.xml","form_type":"4"}},{"id":3862279,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":163840,"kind":"organization","name":"THIRD ROCK VENTURES LP","position":1,"cik":"0001408591","reported_name":"THIRD ROCK VENTURES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163841,"kind":"organization","name":"Third Rock Ventures GP, L.P.","position":2,"cik":"0001578976","reported_name":"Third Rock Ventures GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105938,"kind":"organization","name":"TRV GP, LLC","position":3,"cik":"0001578973","reported_name":"TRV GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series F Preferred Stock","published_at":"2018-07-24T19:19:16.000Z","date":"2018-07-23","kind":"exercise","acquired":false,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are directly held by Third Rock Ventures, L.P. (\"TRV\"). The general partner of TRV is Third Rock Ventures GP, L.P. (\"TRV GP\"). The general partner of TRV GP is TRV GP, LLC (\"TRV GP LLC\"). The individual managers of TRV GP LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP, TRV GP LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares"}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":90840},"source":{"system":"sec-edgar","filing":"0000899243-18-020534","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924318020534/doc4.xml","form_type":"4"}},{"id":3862278,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":163840,"kind":"organization","name":"THIRD ROCK VENTURES LP","position":1,"cik":"0001408591","reported_name":"THIRD ROCK VENTURES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163841,"kind":"organization","name":"Third Rock Ventures GP, L.P.","position":2,"cik":"0001578976","reported_name":"Third Rock Ventures GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105938,"kind":"organization","name":"TRV GP, LLC","position":3,"cik":"0001578973","reported_name":"TRV GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E-1 Preferred Stock","published_at":"2018-07-24T19:19:16.000Z","date":"2018-07-23","kind":"exercise","acquired":false,"shares":3107930,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are directly held by Third Rock Ventures, L.P. (\"TRV\"). The general partner of TRV is Third Rock Ventures GP, L.P. (\"TRV GP\"). The general partner of TRV GP is TRV GP, LLC (\"TRV GP LLC\"). The individual managers of TRV GP LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP, TRV GP LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares"}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":282308},"source":{"system":"sec-edgar","filing":"0000899243-18-020534","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924318020534/doc4.xml","form_type":"4"}},{"id":3862277,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":163840,"kind":"organization","name":"THIRD ROCK VENTURES LP","position":1,"cik":"0001408591","reported_name":"THIRD ROCK VENTURES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163841,"kind":"organization","name":"Third Rock Ventures GP, L.P.","position":2,"cik":"0001578976","reported_name":"Third Rock Ventures GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105938,"kind":"organization","name":"TRV GP, LLC","position":3,"cik":"0001578973","reported_name":"TRV GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E Preferred Stock","published_at":"2018-07-24T19:19:16.000Z","date":"2018-07-23","kind":"exercise","acquired":false,"shares":2285640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are directly held by Third Rock Ventures, L.P. (\"TRV\"). The general partner of TRV is Third Rock Ventures GP, L.P. (\"TRV GP\"). The general partner of TRV GP is TRV GP, LLC (\"TRV GP LLC\"). The individual managers of TRV GP LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP, TRV GP LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares"}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":266934},"source":{"system":"sec-edgar","filing":"0000899243-18-020534","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924318020534/doc4.xml","form_type":"4"}},{"id":3862276,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":163840,"kind":"organization","name":"THIRD ROCK VENTURES LP","position":1,"cik":"0001408591","reported_name":"THIRD ROCK VENTURES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163841,"kind":"organization","name":"Third Rock Ventures GP, L.P.","position":2,"cik":"0001578976","reported_name":"Third Rock Ventures GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105938,"kind":"organization","name":"TRV GP, LLC","position":3,"cik":"0001578973","reported_name":"TRV GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Preferred Stock","published_at":"2018-07-24T19:19:16.000Z","date":"2018-07-23","kind":"exercise","acquired":false,"shares":1086411,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are directly held by Third Rock Ventures, L.P. (\"TRV\"). The general partner of TRV is Third Rock Ventures GP, L.P. (\"TRV GP\"). The general partner of TRV GP is TRV GP, LLC (\"TRV GP LLC\"). The individual managers of TRV GP LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP, TRV GP LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares"}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":98683},"source":{"system":"sec-edgar","filing":"0000899243-18-020534","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924318020534/doc4.xml","form_type":"4"}},{"id":3862275,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":163840,"kind":"organization","name":"THIRD ROCK VENTURES LP","position":1,"cik":"0001408591","reported_name":"THIRD ROCK VENTURES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163841,"kind":"organization","name":"Third Rock Ventures GP, L.P.","position":2,"cik":"0001578976","reported_name":"Third Rock Ventures GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105938,"kind":"organization","name":"TRV GP, LLC","position":3,"cik":"0001578973","reported_name":"TRV GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2018-07-24T19:19:16.000Z","date":"2018-07-23","kind":"exercise","acquired":false,"shares":10650000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are directly held by Third Rock Ventures, L.P. (\"TRV\"). The general partner of TRV is Third Rock Ventures GP, L.P. (\"TRV GP\"). The general partner of TRV GP is TRV GP, LLC (\"TRV GP LLC\"). The individual managers of TRV GP LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP, TRV GP LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares"}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":967389},"source":{"system":"sec-edgar","filing":"0000899243-18-020534","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924318020534/doc4.xml","form_type":"4"}},{"id":3862274,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":163840,"kind":"organization","name":"THIRD ROCK VENTURES LP","position":1,"cik":"0001408591","reported_name":"THIRD ROCK VENTURES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163841,"kind":"organization","name":"Third Rock Ventures GP, L.P.","position":2,"cik":"0001578976","reported_name":"Third Rock Ventures GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105938,"kind":"organization","name":"TRV GP, LLC","position":3,"cik":"0001578973","reported_name":"TRV GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2018-07-24T19:19:16.000Z","date":"2018-07-23","kind":"exercise","acquired":false,"shares":11000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are directly held by Third Rock Ventures, L.P. (\"TRV\"). The general partner of TRV is Third Rock Ventures GP, L.P. (\"TRV GP\"). The general partner of TRV GP is TRV GP, LLC (\"TRV GP LLC\"). The individual managers of TRV GP LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP, TRV GP LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares"}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":999180},"source":{"system":"sec-edgar","filing":"0000899243-18-020534","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924318020534/doc4.xml","form_type":"4"}},{"id":3862273,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":163840,"kind":"organization","name":"THIRD ROCK VENTURES LP","position":1,"cik":"0001408591","reported_name":"THIRD ROCK VENTURES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163841,"kind":"organization","name":"Third Rock Ventures GP, L.P.","position":2,"cik":"0001578976","reported_name":"Third Rock Ventures GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105938,"kind":"organization","name":"TRV GP, LLC","position":3,"cik":"0001578973","reported_name":"TRV GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-07-24T19:19:16.000Z","date":"2018-07-23","kind":"purchase","acquired":true,"shares":266667,"price":15,"value":4000005.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are directly held by Third Rock Ventures, L.P. (\"TRV\"). The general partner of TRV is Third Rock Ventures GP, L.P. (\"TRV GP\"). The general partner of TRV GP is TRV GP, LLC (\"TRV GP LLC\"). The individual managers of TRV GP LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP, TRV GP LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares"}],"balance_after":2983051,"source":{"system":"sec-edgar","filing":"0000899243-18-020534","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924318020534/doc4.xml","form_type":"4"}},{"id":3862272,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":163840,"kind":"organization","name":"THIRD ROCK VENTURES LP","position":1,"cik":"0001408591","reported_name":"THIRD ROCK VENTURES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163841,"kind":"organization","name":"Third Rock Ventures GP, L.P.","position":2,"cik":"0001578976","reported_name":"Third Rock Ventures GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105938,"kind":"organization","name":"TRV GP, LLC","position":3,"cik":"0001578973","reported_name":"TRV GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-07-24T19:19:16.000Z","date":"2018-07-23","kind":"exercise","acquired":true,"shares":2705334,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are directly held by Third Rock Ventures, L.P. (\"TRV\"). The general partner of TRV is Third Rock Ventures GP, L.P. (\"TRV GP\"). The general partner of TRV GP is TRV GP, LLC (\"TRV GP LLC\"). The individual managers of TRV GP LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP, TRV GP LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares"}],"balance_after":2716384,"source":{"system":"sec-edgar","filing":"0000899243-18-020534","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924318020534/doc4.xml","form_type":"4"}},{"id":4183069,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":163840,"kind":"organization","name":"THIRD ROCK VENTURES LP","position":1,"cik":"0001408591","reported_name":"THIRD ROCK VENTURES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163841,"kind":"organization","name":"Third Rock Ventures GP, L.P.","position":2,"cik":"0001578976","reported_name":"Third Rock Ventures GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105938,"kind":"organization","name":"TRV GP, LLC","position":3,"cik":"0001578973","reported_name":"TRV GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-10-19T16:00:34.000Z","date":"2017-10-18","kind":"other","acquired":false,"shares":1000000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a Rule 10b5-1 trading plan adopted by Third Rock Ventures, L.P. (\"TRV\"), TRV distributed on October 18, 2017, for no consideration, 1,000,000 shares of Common Stock of the Issuer (the \"Shares\") to its limited partners and to Third Rock Ventures GP, L.P. (\"TRV GP\"), the general partner of TRV, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP distributed, for no consideration, the Shares it received in the distribution by TRV to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a Rule 10b5-1 trading plan adopted by Third Rock Ventures, L.P. (\"TRV\"), TRV distributed on October 18, 2017, for no consideration, 1,000,000 shares of Common Stock of the Issuer (the \"Shares\") to its limited partners and to Third Rock Ventures GP, L.P. (\"TRV GP\"), the general partner of TRV, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP distributed, for no consideration, the Shares it received in the distribution by TRV to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by TRV. The general partner of TRV is TRV GP. The general partner of TRV GP is TRV GP, LLC (\"TRV GP LLC\"). The individual managers of TRV GP LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP, TRV GP LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":3320348,"source":{"system":"sec-edgar","filing":"0000899243-17-024464","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924317024464/doc4.xml","form_type":"4"}},{"id":4188153,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":163840,"kind":"organization","name":"THIRD ROCK VENTURES LP","position":1,"cik":"0001408591","reported_name":"THIRD ROCK VENTURES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163841,"kind":"organization","name":"Third Rock Ventures GP, L.P.","position":2,"cik":"0001578976","reported_name":"Third Rock Ventures GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105938,"kind":"organization","name":"TRV GP, LLC","position":3,"cik":"0001578973","reported_name":"TRV GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1 Junior Preferred Stock","published_at":"2017-10-11T16:00:26.000Z","date":"2017-10-10","kind":"exercise","acquired":false,"shares":26868642,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series A Convertible Preferred Stock and Series A-1 Junior Preferred Stock converted into Common Stock on a 9.17-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Convertible Preferred Stock and Series A-1 Junior Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series A Convertible Preferred Stock and Series A-1 Junior Preferred Stock converted into Common Stock on a 9.17-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Convertible Preferred Stock and Series A-1 Junior Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series A Convertible Preferred Stock and Series A-1 Junior Preferred Stock converted into Common Stock on a 9.17-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Convertible Preferred Stock and Series A-1 Junior Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These shares are directly held by TRV. The general partner of TRV is Third Rock Ventures GP, L.P. (\"TRV GP\"). The general partner of TRV GP is TRV GP, LLC (\"TRV GP LLC\"). The individual managers of TRV GP LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP, TRV GP LLC, Levin, Starr and Tepper disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2930059},"source":{"system":"sec-edgar","filing":"0000899243-17-024006","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924317024006/doc4.xml","form_type":"4"}},{"id":4188152,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":163840,"kind":"organization","name":"THIRD ROCK VENTURES LP","position":1,"cik":"0001408591","reported_name":"THIRD ROCK VENTURES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163841,"kind":"organization","name":"Third Rock Ventures GP, L.P.","position":2,"cik":"0001578976","reported_name":"Third Rock Ventures GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105938,"kind":"organization","name":"TRV GP, LLC","position":3,"cik":"0001578973","reported_name":"TRV GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2017-10-11T16:00:26.000Z","date":"2017-10-10","kind":"exercise","acquired":false,"shares":9479502,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series A Convertible Preferred Stock and Series A-1 Junior Preferred Stock converted into Common Stock on a 9.17-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Convertible Preferred Stock and Series A-1 Junior Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series A Convertible Preferred Stock and Series A-1 Junior Preferred Stock converted into Common Stock on a 9.17-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Convertible Preferred Stock and Series A-1 Junior Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series A Convertible Preferred Stock and Series A-1 Junior Preferred Stock converted into Common Stock on a 9.17-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Convertible Preferred Stock and Series A-1 Junior Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These shares are directly held by TRV. The general partner of TRV is Third Rock Ventures GP, L.P. (\"TRV GP\"). The general partner of TRV GP is TRV GP, LLC (\"TRV GP LLC\"). The individual managers of TRV GP LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP, TRV GP LLC, Levin, Starr and Tepper disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1033751},"source":{"system":"sec-edgar","filing":"0000899243-17-024006","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924317024006/doc4.xml","form_type":"4"}},{"id":4188151,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":163840,"kind":"organization","name":"THIRD ROCK VENTURES LP","position":1,"cik":"0001408591","reported_name":"THIRD ROCK VENTURES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163841,"kind":"organization","name":"Third Rock Ventures GP, L.P.","position":2,"cik":"0001578976","reported_name":"Third Rock Ventures GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105938,"kind":"organization","name":"TRV GP, LLC","position":3,"cik":"0001578973","reported_name":"TRV GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-10-11T16:00:26.000Z","date":"2017-10-10","kind":"exercise","acquired":true,"shares":3963810,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the total number of shares of Common Stock received by Third Rock Ventures, L.P. (\"TRV\") upon conversion of the Series A Convertible Preferred Stock and Series A-1 Junior Preferred Stock of the Issuer in connection with the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series A Convertible Preferred Stock and Series A-1 Junior Preferred Stock converted into Common Stock on a 9.17-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Convertible Preferred Stock and Series A-1 Junior Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These shares are directly held by TRV. The general partner of TRV is Third Rock Ventures GP, L.P. (\"TRV GP\"). The general partner of TRV GP is TRV GP, LLC (\"TRV GP LLC\"). The individual managers of TRV GP LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP, TRV GP LLC, Levin, Starr and Tepper disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":3981437,"source":{"system":"sec-edgar","filing":"0000899243-17-024006","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924317024006/doc4.xml","form_type":"4"}},{"id":4257802,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":163840,"kind":"organization","name":"THIRD ROCK VENTURES LP","position":1,"cik":"0001408591","reported_name":"THIRD ROCK VENTURES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163841,"kind":"organization","name":"Third Rock Ventures GP, L.P.","position":2,"cik":"0001578976","reported_name":"Third Rock Ventures GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105938,"kind":"organization","name":"TRV GP, LLC","position":3,"cik":"0001578973","reported_name":"TRV GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-07-13T20:07:52.000Z","date":"2017-07-13","kind":"other","acquired":false,"shares":850000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a Rule 10b5-1 trading plan adopted by Third Rock Ventures, L.P. (\"TRV\"), TRV distributed on July 13, 2017, for no consideration, 850,000 shares of Common Stock of the Issuer (the \"Shares\") to its limited partners and to Third Rock Ventures GP, L.P. (\"TRV GP\"), the general partner of TRV, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP distributed, for no consideration, the Shares it received in the distribution by TRV to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a Rule 10b5-1 trading plan adopted by Third Rock Ventures, L.P. (\"TRV\"), TRV distributed on July 13, 2017, for no consideration, 850,000 shares of Common Stock of the Issuer (the \"Shares\") to its limited partners and to Third Rock Ventures GP, L.P. (\"TRV GP\"), the general partner of TRV, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP distributed, for no consideration, the Shares it received in the distribution by TRV to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by TRV. The general partner of TRV is TRV GP. The general partner of TRV GP is TRV GP, LLC (\"TRV GP LLC\"). The individual managers of TRV GP LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP, TRV GP LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":4320348,"source":{"system":"sec-edgar","filing":"0000899243-17-018238","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924317018238/doc4.xml","form_type":"4"}},{"id":4371650,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":163840,"kind":"organization","name":"THIRD ROCK VENTURES LP","position":1,"cik":"0001408591","reported_name":"THIRD ROCK VENTURES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163841,"kind":"organization","name":"Third Rock Ventures GP, L.P.","position":2,"cik":"0001578976","reported_name":"Third Rock Ventures GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105938,"kind":"organization","name":"TRV GP, LLC","position":3,"cik":"0001578973","reported_name":"TRV GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-03-27T19:28:16.000Z","date":"2017-03-27","kind":"sale","acquired":false,"shares":650000,"price":18.0003,"value":11700195.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.45, inclusive. Each of the reporting persons undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are directly held by Third Rock Ventures, L.P. (\"TRV\"). The general partner of TRV is Third Rock Ventures GP, L.P. (\"TRV GP\"). The general partner of TRV GP is TRV GP, LLC (\"TRV GP LLC\"). The individual managers of TRV GP LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP, TRV GP LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":5170348,"source":{"system":"sec-edgar","filing":"0000899243-17-008731","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924317008731/doc4.xml","form_type":"4"}},{"id":4371649,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":163840,"kind":"organization","name":"THIRD ROCK VENTURES LP","position":1,"cik":"0001408591","reported_name":"THIRD ROCK VENTURES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163841,"kind":"organization","name":"Third Rock Ventures GP, L.P.","position":2,"cik":"0001578976","reported_name":"Third Rock Ventures GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105938,"kind":"organization","name":"TRV GP, LLC","position":3,"cik":"0001578973","reported_name":"TRV GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-03-27T19:28:16.000Z","date":"2017-03-23","kind":"sale","acquired":false,"shares":1000000,"price":17.0002,"value":17000200.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are directly held by Third Rock Ventures, L.P. (\"TRV\"). The general partner of TRV is Third Rock Ventures GP, L.P. (\"TRV GP\"). The general partner of TRV GP is TRV GP, LLC (\"TRV GP LLC\"). The individual managers of TRV GP LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP, TRV GP LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":5820348,"source":{"system":"sec-edgar","filing":"0000899243-17-008731","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924317008731/doc4.xml","form_type":"4"}},{"id":4382566,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":163840,"kind":"organization","name":"THIRD ROCK VENTURES LP","position":1,"cik":"0001408591","reported_name":"THIRD ROCK VENTURES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163841,"kind":"organization","name":"Third Rock Ventures GP, L.P.","position":2,"cik":"0001578976","reported_name":"Third Rock Ventures GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105938,"kind":"organization","name":"TRV GP, LLC","position":3,"cik":"0001578973","reported_name":"TRV GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-03-16T17:30:24.000Z","date":"2017-03-15","kind":"other","acquired":false,"shares":850000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a Rule 10b5-1 trading plan adopted by Third Rock Ventures, L.P. (\"TRV\"), TRV distributed on March 15, 2017, for no consideration, 850,000 shares of Common Stock of the Issuer (the \"Shares\") to its limited partners and to Third Rock Ventures GP, L.P. (\"TRV GP\"), the general partner of TRV, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP distributed, for no consideration, the Shares it received in the distribution by TRV to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a Rule 10b5-1 trading plan adopted by Third Rock Ventures, L.P. (\"TRV\"), TRV distributed on March 15, 2017, for no consideration, 850,000 shares of Common Stock of the Issuer (the \"Shares\") to its limited partners and to Third Rock Ventures GP, L.P. (\"TRV GP\"), the general partner of TRV, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP distributed, for no consideration, the Shares it received in the distribution by TRV to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by TRV. The general partner of TRV is TRV GP. The general partner of TRV GP is TRV GP, LLC (\"TRV GP LLC\"). The individual managers of TRV GP LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP, TRV GP LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":6820348,"source":{"system":"sec-edgar","filing":"0000899243-17-007785","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924317007785/doc4.xml","form_type":"4"}},{"id":4562260,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":163840,"kind":"organization","name":"THIRD ROCK VENTURES LP","position":1,"cik":"0001408591","reported_name":"THIRD ROCK VENTURES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163841,"kind":"organization","name":"Third Rock Ventures GP, L.P.","position":2,"cik":"0001578976","reported_name":"Third Rock Ventures GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105938,"kind":"organization","name":"TRV GP, LLC","position":3,"cik":"0001578973","reported_name":"TRV GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-09T16:05:19.000Z","date":"2016-11-07","kind":"other","acquired":false,"shares":1000000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 7, 2016, Third Rock Ventures, L.P. (\"TRV\") distributed, for no consideration, 1,000,000 shares of Common Stock of the Issuer (the \"Shares\") to its limited partners and to Third Rock Ventures GP, L.P. (\"TRV GP\"), the general partner of TRV, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP distributed, for no consideration, the Shares it received in the distribution by TRV to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 7, 2016, Third Rock Ventures, L.P. (\"TRV\") distributed, for no consideration, 1,000,000 shares of Common Stock of the Issuer (the \"Shares\") to its limited partners and to Third Rock Ventures GP, L.P. (\"TRV GP\"), the general partner of TRV, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP distributed, for no consideration, the Shares it received in the distribution by TRV to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by TRV. The general partner of TRV is TRV GP. The general partner of TRV GP is TRV GP, LLC (\"TRV GP LLC\"). The individual managers of TRV GP LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP, TRV GP LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":7670348,"source":{"system":"sec-edgar","filing":"0000899243-16-033012","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924316033012/doc4.xml","form_type":"4"}}]}